Effects of titanium dioxide nanoparticle exposure on neuroimmune responses in rat airways.
Exposure to ambient nanoparticles (defined as particulate matter [PM] having one dimension <100 nm) is associated with increased risk of childhood and adult asthma. Nanomaterials feature a smaller aerodynamic diameter and a higher surface area per unit mass ratio compared to fine or coarse-sized particles, resulting in greater lung deposition efficiency and an increased potential for biological interaction. The neurotrophins nerve growth factor and brain-derived neurotrophic factor are key regulatory elements of neuronal development and responsiveness of airway sensory neurons. Changes in their expression are associated with bronchoconstriction, airway hyperresponsiveness, and airway inflammation. The neurogenic-mediated control of airway responses is a key pathophysiological mechanism of childhood asthma. However, the effects of nanoparticle exposure on neurotrophin-driven airway responses and their potential role as a predisposing factor for developing asthma have not been clearly elucidated. In this study, in vivo inhalation exposure to titanium dioxide nanoparticles (12 mg/m(3); 5.6 h/d for 3 d) produced upregulation of lung neurotrophins in weanling (2-wk-old) and newborn (2-d-old) rats but not in adult (12-wk-old) animals compared to controls. This effect was associated with increased airway responsiveness and upregulation of growth-related oncogene/keratine-derived chemokine (GRO/KC; CXCL1, rat equivalent of human interleukin [IL]-8) in bronchoalveolar lavage fluid. These data show for the first time that exposure to nanoparticulate upregulates the expression of lung neurotrophins in an age-dependent fashion and that this effect is associated with airway hyperresponsiveness and inflammation. These results suggest the presence of a critical window of vulnerability in earlier stages of lung development, which may lead to a higher risk of developing asthma.
Scuri
Mario
M
Department of Pediatrics, West Virginia University School of Medicine, Morgantown, West Virginia 26506, USA. mscuri@hsc.wvu.edu
Chen
Bean T
BT
Castranova
Vincent
V
Reynolds
Jeffrey S
JS
Johnson
Victor J
VJ
Samsell
Lennie
L
Walton
Cheryl
C
Piedimonte
Giovanni
G
D000367:Age Factors; D000818:Animals; D001249:Asthma / Q000139:chemically induced / Q000276:immunology / Q000473:pathology; D005260:Female; D019570:Inhalation Exposure / Q000009:adverse effects*; D008297:Male; D053758:Nanoparticles; D015213:Neuroimmunomodulation / Q000187:drug effects* / Q000276:immunology; D011650:Pulmonary Alveoli / Q000187:drug effects* / Q000378:metabolism; D051381:Rats; D018570:Risk Assessment; D014025:Titanium / Q000008:administration & dosage / Q000633:toxicity*
C009495:titanium dioxide; D014025:Titanium
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1860-6
11734437
Toxicol Lett. 2005 Aug 14;158(2):122-32
16039401
J Toxicol Environ Health A. 2007 Feb 1;70(3-4):261-5
17365587
Am J Respir Cell Mol Biol. 2008 Mar;38(3):371-6
17947511
Am Ind Hyg Assoc J. 1978 Jan;39(1):26-32
204181
Respir Res. 2002;3 Suppl 1:S21-5
12119054
Environ Health Perspect. 2006 Dec;114(12):1818-25
17185269
Am J Respir Cell Mol Biol. 2008 May;38(5):579-90
18096873
Int Arch Allergy Immunol. 1999 Feb-Apr;118(2-4):163-5
10224367
J Appl Physiol (1985). 2008 Aug;105(2):711-7
18450981
Nature. 1989 Jan 26;337(6205):362-4
2911387
J Pediatr. 1998 May;132(5):849-53
9602198
Toxicol Appl Pharmacol. 2007 Jul 15;222(2):141-51
17599375
Acta Paediatr Suppl. 2002;91(437):6-11
12200895
Part Fibre Toxicol. 2005 Oct 06;2:8
16209704
Environ Res. 2009 Apr;109(3):321-7
19211100
Nature. 2006 Nov 16;444(7117):267-9
17108940
Pharmacol Ther. 2006 Oct;112(1):116-38
16730375
Respir Med. 2002 Apr;96 Suppl B:S25-9
11996401
Arch Dis Child. 1999 Apr;80(4):343-7
10086941
Arch Neurol. 2000 May;57(5):654-7
10815130
J Toxicol Environ Health A. 2005 Jul 9-23;68(13-14):1093-109
16024490
Int Arch Occup Environ Health. 2001 Jan;74(1):1-8
11196075
Eur Respir J. 2002 Sep;20(3):691-702
12358349
J Toxicol Environ Health A. 2005 Jul 9-23;68(13-14):1071-92
16024489
J Toxicol Environ Health A. 2007 Feb 1;70(3-4):275-83
17365590
Science. 1987 Sep 4;237(4819):1154-62
3306916
Part Fibre Toxicol. 2007 May 30;4:4
17537262
Nanomedicine. 2006 Jun;2(2):121-6
17292124
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 2):S18-21
11254547
Arch Dis Child. 2000 Feb;82(2):126-30
10648365
Am J Physiol Lung Cell Mol Physiol. 2002 Aug;283(2):L494-502
12114213
Rev Environ Health. 1998 Jan-Jun;13(1-2):59-71
9718622
J Occup Health. 2003 Jan;45(1):23-30
14605425
Inhal Toxicol. 2005 Jun-Jul;17(7-8):355-85
16020034
Toxicol Sci. 2003 Apr;72(2):339-46
12655033
Regul Pept. 1997 Jun 18;70(2-3):75-90
9272619
Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1044-50
17714092
N Engl J Med. 2004 Oct 21;351(17):1721-30
15496621
J Toxicol Environ Health A. 2002 Oct 25;65(20):1513-30
12396866
Pediatr Res. 2004 Apr;55(4):657-65
14711892
Eur J Immunol. 1998 Oct;28(10):3240-51
9808193
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10955-60
8855290
Am J Respir Crit Care Med. 2008 Feb 15;177(4):426-32
17932382
Pediatr Infect Dis J. 2003 Feb;22(2 Suppl):S66-74; discussion S74-5
12671455
Int Arch Allergy Immunol. 1995 May-Jun;107(1-3):202-4
7613131
J Allergy Clin Immunol. 2006 Jan;117(1):67-71
16387586
Environ Health Perspect. 2007 Mar;115(3):397-402
17431489
Annu Rev Neurosci. 2001;24:677-736
11520916
Curr Opin Pulm Med. 2004 Jan;10(1):62-6
14749608
Toxicology. 2007 Jan 25;230(1):90-104
17196727
Respir Res. 2000;1(1):12-5
11667958
Annu Rev Neurosci. 1996;19:289-317
8833445
Chin Med J (Engl). 1999 Nov;112(11):985-7
11721480
Clin Exp Allergy. 1996 Mar;26(3):357-62
8729675
Nat Rev Neurosci. 2003 Apr;4(4):299-309
12671646
Pharm Res. 2004 Feb;21(2):344-53
15032318
J Allergy Clin Immunol. 2006 Mar;117(3):583-9
16522457
Am J Respir Crit Care Med. 2005 Jul 15;172(2):256
16002576
Eur J Pharmacol. 2006 Mar 8;533(1-3):195-206
16458292
Toxicol Appl Pharmacol. 2003 Jul 15;190(2):157-69
12878045
Clin Exp Allergy. 2006 Nov;36(11):1469-79
17083358